Ginkgo Bioworks DNA Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ginkgo Bioworks's short- and long-term operating lease liabilities?
- Ginkgo Bioworks (DNA) reported short- and long-term operating lease liabilities of -$5M in Q1 2026.
- How has Ginkgo Bioworks's short- and long-term operating lease liabilities changed year-over-year?
- Ginkgo Bioworks's short- and long-term operating lease liabilities decreased by 4.3% year-over-year, from -$4.79M to -$5M.
- What is the long-term trend for Ginkgo Bioworks's short- and long-term operating lease liabilities?
- Over 2 years (2023 to 2025), Ginkgo Bioworks's short- and long-term operating lease liabilities has grown at a 10.7% compound annual growth rate (CAGR), from -$22.8M to -$27.93M.